Literature DB >> 12675039

Appropriate antibiotic therapy for ventilator-associated pneumonia and sepsis: a necessity, not an issue for debate.

Marin H Kolleff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12675039     DOI： 10.1007/s00134-002-1614-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

1.  Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia.

Authors:  N C Dean; M P Silver; K A Bateman; B James; C J Hadlock; D Hale
Journal:  Am J Med       Date:  2001-04-15       Impact factor: 4.965

2.  The quick and the dead: the importance of rapid evaluation of infiltrates in the immunocompromised patient.

Authors:  Andrew F Shorr; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

3.  The value of routine microbial investigation in ventilator-associated pneumonia.

Authors:  J Rello; M Gallego; D Mariscal; R Soñora; J Valles
Journal:  Am J Respir Crit Care Med       Date:  1997-07       Impact factor: 21.405

4.  Pneumonia mortality reduction and quality improvement in a community hospital.

Authors:  R N McGarvey; J J Harper
Journal:  QRB Qual Rev Bull       Date:  1993-04

5.  The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.

Authors:  M H Kollef; S Ward
Journal:  Chest       Date:  1998-02       Impact factor: 9.410

Review 6.  Antibiotic resistance in the intensive care unit.

Authors:  M H Kollef; V J Fraser
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

7.  Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.

Authors:  C M Luna; P Vujacich; M S Niederman; C Vay; C Gherardi; J Matera; E C Jolly
Journal:  Chest       Date:  1997-03       Impact factor: 9.410

8.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

9.  Prognostic factors of non-HIV immunocompromised patients with pulmonary infiltrates.

Authors:  Ana Rañó; Carlos Agustí; Natividad Benito; Montserrat Rovira; Joaquim Angrill; Tomás Pumarola; Antoni Torres
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

10.  Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group.

Authors:  F Alvarez-Lerma
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440
View more
  5 in total

Review 1.  Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia.

Authors:  Victor L Yu; Nina Singh
Journal:  Intensive Care Med       Date:  2004-02-28       Impact factor: 17.440

2.  Antibiotic prescribing for ventilator-associated pneumonia: get it right from the beginning but be able to rapidly deescalate.

Authors:  Jean Chastre
Journal:  Intensive Care Med       Date:  2005-09-07       Impact factor: 17.440

3.  Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection.

Authors:  Charalambos Gogos; Antigone Kotsaki; Aimilia Pelekanou; George Giannikopoulos; Ilia Vaki; Panagiota Maravitsa; Stephanos Adamis; Zoi Alexiou; George Andrianopoulos; Anastasia Antonopoulou; Sofia Athanassia; Fotini Baziaka; Aikaterini Charalambous; Sofia Christodoulou; Ioanna Dimopoulou; Ioannis Floros; Efthymia Giannitsioti; Panagiotis Gkanas; Aikaterini Ioakeimidou; Kyriaki Kanellakopoulou; Niki Karabela; Vassiliki Karagianni; Ioannis Katsarolis; Georgia Kontopithari; Petros Kopterides; Ioannis Koutelidakis; Pantelis Koutoukas; Hariklia Kranidioti; Michalis Lignos; Konstantinos Louis; Korina Lymberopoulou; Efstratios Mainas; Androniki Marioli; Charalambos Massouras; Irini Mavrou; Margarita Mpalla; Martha Michalia; Heleni Mylona; Vassilios Mytas; Ilias Papanikolaou; Konstantinos Papanikolaou; Maria Patrani; Ioannis Perdios; Diamantis Plachouras; Aikaterini Pistiki; Konstantinos Protopapas; Kalliopi Rigaki; Vissaria Sakka; Monika Sartzi; Vassilios Skouras; Maria Souli; Aikaterini Spyridaki; Ioannis Strouvalis; Thomas Tsaganos; George Zografos; Konstantinos Mandragos; Phylis Klouva-Molyvdas; Nina Maggina; Helen Giamarellou; Apostolos Armaganidis; Evangelos J Giamarellos-Bourboulis
Journal:  Crit Care       Date:  2010-05-26       Impact factor: 9.097

4.  Early changes of the kinetics of monocyte trem-1 reflect final outcome in human sepsis.

Authors:  Androniki Marioli; Marina Koupetori; Maria Raftogiannis; Maria Patrani; Nikolaos Antonakos; Maria Pavlaki; Georgios Adamis; Georgia Dougekou; Georgia Damoraki; Iraklis Tsangaris
Journal:  BMC Immunol       Date:  2014-12-23       Impact factor: 3.615

5.  Candidemia in the critically ill: initial therapy and outcome in mechanically ventilated patients.

Authors:  Marcela A Ferrada; Andrew A Quartin; Daniel H Kett; Michele I Morris
Journal:  BMC Anesthesiol       Date:  2013-10-30       Impact factor: 2.217
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.